ArticleBritish journal of clinical pharmacology2025

Risk factors for lenvatinib-induced hypertension in patients with hepatocellular carcinoma: A retrospective study.

Shusuke Uekusa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.